ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 92 filers reported holding ENZO BIOCHEM INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $84,000 | -16.8% | 23,399 | -21.7% | 0.00% | -33.3% |
| Q2 2019 | $101,000 | +21.7% | 29,899 | +47.4% | 0.01% | +50.0% |
| Q3 2018 | $83,000 | -27.8% | 20,282 | -3.5% | 0.00% | -20.0% |
| Q1 2018 | $115,000 | -0.9% | 21,007 | +98.7% | 0.01% | -16.7% |
| Q2 2017 | $116,000 | +14.9% | 10,573 | -38.0% | 0.01% | +20.0% |
| Q2 2016 | $101,000 | +44.3% | 17,061 | +25.2% | 0.01% | +66.7% |
| Q3 2014 | $70,000 | +11.1% | 13,625 | +12.4% | 0.00% | 0.0% |
| Q2 2014 | $63,000 | – | 12,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |